Similarly, ProGRP and NSE have been identified as valuable markers for differentiating pulmonary masses, with ProGRP showing particularly high diagnostic value (AUC = 0.975) in distinguishing NSCLC from SCLC. This evidence concerns the gene ENO2 and non-small cell lung carcinoma.